These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3492195)

  • 1. Forskolin sensitizes human platelet adenylate cyclase to modulation of substrate (MgATP) affinity by hormones.
    Watanabe Y; Jakobs KH
    Biochem J; 1986 Jul; 237(1):273-6. PubMed ID: 3492195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
    Spence S; Houslay MD
    Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation and inhibition of rat basophilic leukemia cell adenylate cyclase by forskolin.
    Jakobs KH; Watanabe Y
    Biochim Biophys Acta; 1985 Sep; 846(3):356-63. PubMed ID: 3899183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between forskolin and calcium-calmodulin stimulation of rat cerebral cortex adenylate cyclase: enzyme activation modulates substrate (MgATP) affinity.
    Uhlén S; Wikberg JE
    Pharmacol Toxicol; 1988 Aug; 63(2):90-5. PubMed ID: 3186624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C interferes with Ni-mediated inhibition of human platelet adenylate cyclase.
    Watanabe Y; Horn F; Bauer S; Jakobs KH
    FEBS Lett; 1985 Nov; 192(1):23-7. PubMed ID: 4054315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.
    Jakobs KH; Bauer S; Watanabe Y
    Eur J Biochem; 1985 Sep; 151(2):425-30. PubMed ID: 4040856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet adenylate cyclase: persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities.
    Olson CV; Smiley PA; Lad PM
    Biochim Biophys Acta; 1985 Jun; 845(3):411-20. PubMed ID: 3924118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenylate cyclase activity during the reversible shape change in human platelets.
    Dimitrov DP; Bühler FR
    Biochem Biophys Res Commun; 1988 Apr; 152(2):649-57. PubMed ID: 3365246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes.
    Stein JM; Martin BR
    Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets.
    Willuweit B; Aktories K
    Biochem J; 1988 Feb; 249(3):857-63. PubMed ID: 2833229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of sodium and other monovalent cations on human platelet adenylate cyclase.
    Steer ML; Wood A
    J Biol Chem; 1981 Oct; 256(19):9990-3. PubMed ID: 7196915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?
    Michel MC; Klüppel M; Philipp T; Brodde OE
    Br J Clin Pharmacol; 1991 Jul; 32(1):105-9. PubMed ID: 1679657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of adenylate cyclase of human platelet membranes by forskolin.
    Insel PA; Stengel D; Ferry N; Hanoune J
    J Biol Chem; 1982 Jul; 257(13):7485-90. PubMed ID: 7045106
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenylate cyclase of platelets from spontaneously hypertensive rats: reduction of the inhibition by GTP.
    Coquil JF; Brunelle G
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1265-71. PubMed ID: 2504157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of human platelet adenylate cyclase by stable GTP analogs and epinephrine.
    Jakobs KH; Aktories K
    Biochim Biophys Acta; 1983 Jul; 732(2):352-8. PubMed ID: 6409148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.